Reappraising prognostic factors after SRS/FSRT of brain metastases in the era of targeted therapies

被引：0
|
作者：
Fink, Christoph A. [1 ]
Tawk, Bouchra [1 ]
Hahnemann, Laura [1 ]
Christopoulos, Petros [2 ]
Hoerner-Rieber, Juliane [1 ]
Weykamp, Fabian [1 ]
Lang, Kristin [1 ]
Thomas, Michael [2 ]
Debus, Juergen [1 ]
Koenig, Laila [1 ]
机构：
[1] Univ Hosp Heidelberg, Radiat Oncol, Heidelberg, Germany
[2] Dept Thorac Oncol, Thoraxklin, Heidelberg, Germany
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 194卷
关键词：
targeted therapy; checkpoint inhibition; SRS;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1044
引用
收藏
页码：S816 / S819
页数：5
相关论文
共 50 条
  • [31] Brain Metastasis and Renal Cell Carcinoma: Prognostic Scores Assessment in the Era of Targeted Therapies
    El Ali, Ziad
    Rottey, Sylvie
    Barthelemy, Philippe
    Kotecki, Nuria
    Van Paemel, Ruben
    Devrient, Daniel
    Awada, Ahmad
    Gil, Thierry
    Pannier, Diane
    Ryckewaert, Thomas
    Waisse, Waissi
    Clavier, Jean-Baptiste
    Penel, Nicolas
    Vermassen, Tijl
    ANTICANCER RESEARCH, 2019, 39 (06) : 2993 - 3002
  • [32] SRS for Brain Metastases in Non Small Cell Lung Cancer patients: Evaluation of Prognostic Factors
    Fonseca, D. S. L.
    Ercolin, L.
    Fantini, D. F. S.
    Gomes, D. N. S.
    Jacinto, A. A.
    De Mattos, M. D.
    Borges, A. B. B.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S676 - S676
  • [33] Melanoma Brain Metastases: A Retrospective Analysis of Prognostic Factors and Efficacy of Multimodal Therapies
    Interno, Valeria
    Sergi, Maria Chiara
    Metta, Maria Elvira
    Guida, Michele
    Trerotoli, Paolo
    Strippoli, Sabino
    Circelli, Salvatore
    Porta, Camillo
    Tucci, Marco
    CANCERS, 2023, 15 (05)
  • [34] Improved Survival of Patients With Melanoma Brain Metastases in the Era of Targeted BRAF and Immune Checkpoint Therapies
    Sloot, Sarah
    Chen, Yian A.
    Zhao, Xiuhua
    Weber, Jamie L.
    Benedict, Jacob J.
    Mule, James J.
    Smalley, Keiran S.
    Weber, Jeffrey S.
    Zager, Jonathan S.
    Forsyth, Peter A.
    Sondak, Vernon K.
    Gibney, Geoffrey T.
    CANCER, 2018, 124 (02) : 297 - 305
  • [35] FSRT versus SRS for Patients with large Brain Metastases: A volume-based Analysis of local Control and Radionecrosis
    Putz, F.
    Oft, D.
    Lettmaier, S.
    Weissmann, T.
    Fietkau, R.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S35 - S35
  • [36] Melanoma Brain Metastases in the Era of Target Therapies: An Overview
    Becco, Paolo
    Gallo, Susanna
    Poletto, Stefano
    Frascione, Mirko Pio Manlio
    Crotto, Luca
    Zaccagna, Alessandro
    Paruzzo, Luca
    Caravelli, Daniela
    Carnevale-Schianca, Fabrizio
    Aglietta, Massimo
    CANCERS, 2020, 12 (06) : 1 - 20
  • [37] Targeted Therapies for the Treatment of Brain Metastases in Solid Tumors
    Jan-Paul Bohn
    Georg Pall
    Guenther Stockhammer
    Michael Steurer
    Targeted Oncology, 2016, 11 : 263 - 275
  • [38] The progress of microenvironment-targeted therapies in brain metastases
    Long, Lifu
    Yi, Zhenjie
    Zeng, Yu
    Liu, Zhixiong
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [39] Targeted Therapies for the Treatment of Brain Metastases in Solid Tumors
    Bohn, Jan-Paul
    Pall, Georg
    Stockhammer, Guenther
    Steurer, Michael
    TARGETED ONCOLOGY, 2016, 11 (03) : 263 - 275
  • [40] Targeted Therapies for Brain Metastases from Breast Cancer
    Venur, Vyshak Alva
    Leone, Jose Pablo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (09):
12345